Target intelligence / Profile preview

28S ribosomal RNA peptidyl transferase center (28S rRNA PTC)

Target
28S rRNA PTC
Molecular classification
Ribozyme, Ribosomal RNA, Enzyme
01

Overview

The 28S ribosomal RNA peptidyl transferase center (PTC) is the catalytic core of the eukaryotic 60S ribosomal subunit, functioning as a ribozyme to facilitate the formation of peptide bonds during translation (Polacek & Mankin, 2005). Located within the large subunit, the PTC ensures the correct positioning of aminoacyl-tRNA and peptidyl-tRNA to allow the nascent polypeptide chain to grow (Schmeing et al., 2005). This site is a major target for various potent Ribosome-Inactivating Proteins (RIPs), such as ricin and Shiga toxins, which specifically depurinate a conserved adenine residue in the nearby sarcin/ricin loop, effectively halting protein synthesis and leading to cell death (Endo & Tsurugi, 1987). In clinical research, the PTC is exploited through the use of immunotoxins, where toxins targeting the 28S rRNA are linked to antibodies for selective destruction of cancer cells (Grela et al., 2019). Additionally, small molecules like anisomycin and cycloheximide interact with the PTC to inhibit translation, serving as valuable tools in molecular biology and potential leads for therapeutic development. Due to its essential role in all eukaryotic cells, therapeutic strategies involving the PTC require high precision to avoid significant systemic toxicity and damage to healthy tissues.

Other names
Peptidyl transferase centerPTC60S ribosomal subunit catalytic centerLarge ribosomal subunit peptidyl transferase center
02

Mechanism of action

Inhibition of peptide bond formation by blocking the A-site or P-site, or through site-specific depurination of the sarcin/ricin loop which prevents elongation factor binding (Endo & Tsurugi, 1987; Polacek & Mankin, 2005).

03

Biological functions

Protein synthesisPeptide bond formationTranslation elongation
04

Disease associations

CancerInfectionToxicosis
05

Safety considerations

High systemic toxicity due to universal eukaryotic conservationOff-target effects in healthy tissuesVascular leak syndrome associated with toxin-based conjugatesImmunogenicity of protein-derived inhibitors
06

Interacting drugs

Anisomycin

7 more in the full profile.

07

Biomarkers

Depurinated 28S rRNA fragmentsProtein synthesis rate inhibitionApoptotic cell death markers

Beyond the preview

Go deeper on 28S ribosomal RNA peptidyl transferase center (28S rRNA PTC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 28S ribosomal RNA peptidyl transferase center (28S rRNA PTC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call